Sold out
  • Vendor: Mia Karts

Lymphomas (Emerging Cancer Therapeutics, Volume 3, Issue 2)

$116.30 USD
$93.04 USD
 per 

Free U.S. shipping on all orders. Free international shipping on orders over $99

All orders are dispatched the next business day!

Competitive Pricing You Can Trust — Quality You Can Rely On.

Guaranteed safe checkout

Product description

ISBN: 1936287781

Author: Sweetenham MD, John W.

Condition: New

Emerging Cancer Therapeutics is a trinary hard cover periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, housestaff, fellows, practicing clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.With contributions from internationally recognized experts, Lymphomas combines chapters on the evolving role of established therapies such as stem cell transplantation with other disease-oriented chapters describing pathway-directed agents and the evolving paradigm of "personalized" lymphoma treatment. Coverage includes discussion of molecular characterization for different disease-specific lymphoma subtypes and the potential for developing "personalized" treatment as well as reviewing the evolving role of conventional chemotherapy, stem cell transplantation, and other salvage treatments. The articles examine a range of lymphoma subtypes, including Hodgkin lymphoma, T-cell lymphoma, aggressive B-cell lymphoma, and others. "

View full details

Lymphomas (Emerging Cancer Therapeutics, Volume 3, Issue 2)

$116.30 USD
$93.04 USD
 per 
RECENTLY VIEWED PRODUCTS

Free same-day delivery

Free shipping - no code needed, just head for checkout!

Repeat delivery

Repeat delivery with 5% OFF every order.

Curbside pickup

Order online, drive up, check in & pick up.